Invitrogen IVGN | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Invitrogen IVGN

An SI Board Since January 1999

Posts	SubjectMarks	Bans
73	6	0

Emcee: Doug DuBois	Type: Unmoderated

Introduction Compact

Invitrogen is a San Diego based biotech company which is soon to be going public. They make kits for cloning genes as well as supplying materials for biotech research. The IPO date is expected in February. The proposed offer price is $15.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
73	cc call: seekingalpha.com	mopgcw	-	10/22/2008
72	Merrill Company Updates Invitrogen Corp (IVGN, US$38.62, B-1-9) Merger postmort	tom pope	-	6/24/2008
71	<b>Invitrogen to buy Applied Biosystems for $6.4B</b> biz.yahoo.com	idos	-	6/12/2008
70	Merrill Upgrading to a Buy; $52 price target We are upgrading IVGN shares to Bu	tom pope	-	5/30/2008
69	Invitrogen: Stock Will Keep Rising by: Zacks.com posted on: May 04, 2008 \| about	mopgcw	-	5/8/2008
68	pops on the news, unfortunately i never pulled the trigger...alas. Invitrogen A	mopgcw	-	10/31/2007
67	Invitrogen to Hold Meeting for Analysts on Thursday biz.yahoo.com Thursday Aug	idos	-	8/16/2007
66	Invitrogen's 2nd-Quarter Profit Doubles on 13 Percent Revenue Growth CARLSB	idos	-	8/2/2007
65	Invitrogen and Emiliem Sign Major Kinase Screening Agreement 2007-03-29 08:00 (N	mopgcw	-	4/10/2007
64	citi: IVGN: Reduce to Hold; Business Fluctuations Create Uncertain Outlook	mopgcw	-	10/27/2006
63	finance is not my strong side, you have a much better understanding of the figur	idos	-	10/27/2006
62	fwiw, i have generally liked the stock under $60, but need to parse the latest e	mopgcw	-	10/27/2006
61	IVGN fell under 60$ after hours, might be a good entry point?	idos	-	10/27/2006
60	Invitrogen Announces Third Quarter 2006 Results Thursday October 26, 4:05 pm ET	mopgcw	-	10/27/2006
59	IVGN: One Stop Shop for Consumables - Initiating with a Buy Rating BUY (1)	mopgcw	-	10/6/2006
58	>> the iPrep(TM) purification instrument automates nucleic acid purificati	tuck	-	9/26/2006
57	Invitrogen Adds Instrumentation Capability to Reagent Strength with Launch of Tw	mopgcw	-	9/26/2006
56	barron's: Positive Culture By JAY PALMER A LITTLE GENE THERAPY WOULD SEE	mopgcw	-	9/17/2006
55	cc transcript: seekingalpha.com	mopgcw	-	9/4/2006
54	Invitrogen Corporation Expands Cellular Assay Capabilities, To Acquire Sentigen	mopgcw	-	9/1/2006
53	Sentigen Signs Definitive Merger Agreement with Invitrogen Corporation Friday Se	mopgcw	-	9/1/2006
52	Invitrogen Introduces Next Generation of Transfection Reagents Wednesday August	mopgcw	-	9/1/2006
51	BOA upgraded to a buy, lowered price target to $70 from $76 and EPS est to $3.25	mopgcw	-	8/14/2006
50	Invitrogen Announces Second Quarter 2006 Results Thursday August 3, 4:21 pm ET	mopgcw	-	8/4/2006
49	Prodesse, Inc. and Invitrogen Collaborate on First Molecular Diagnostic LUX(TM)	mopgcw	-	7/22/2006

Go to reply# or date (mm/dd/yy):